Sacubitril/valsartan attenuates atrial structural remodelling in atrial fibrillation patients

Abstract Aims Radiofrequency catheter ablation (RFCA) is now an established therapeutic option for patients with atrial fibrillation (AF), but the long‐term recurrence rate of AF is still high. Sacubitril/valsartan (Sac/Val) is superior to valsartan in attenuating ventricular remodelling and improvi...

詳細記述

書誌詳細

主要な著者:	Liu Yang, Min Zhang, Zhiheng Hao, Nan Wang
フォーマット:	Artigo
言語:	Inglês
出版事項:	Oxford University Press 2022-08-01
シリーズ:	ESC Heart Failure
主題:	Atrial fibrillation Sacubitril/valsartan Atrial remodelling AF recurrence Pulmonary vein isolation
オンライン･アクセス:	https://doi.org/10.1002/ehf2.13937
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!